Advertisement
Loading...

C4 Therapeutics, Inc.

CCCC•NASDAQ
Healthcare
Biotechnology
$3.56
$0.04(1.14%)
U.S. Market opens in 1h 34m
Advertisement

C4 Therapeutics, Inc. (CCCC) Stock Overview

Explore C4 Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap294.9M
P/E Ratio-4.32
EPS (TTM)$-1.10
ROE-0.51%
Fundamental Analysis

AI Price Forecasts

1 Month$1.94
3 Months$0.00
1 Year Target$1.73

CCCC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of C4 Therapeutics, Inc. (CCCC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.81, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.73.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -4.32 and a market capitalization of 294.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.14%
5-Day Change
12.66%
1-Month Change
23.61%
3-Month Change
28.52%
6-Month Change
43.55%
Year-to-Date (YTD) Change
86.39%
1-Year Change
173.85%
3-Year Change
14.47%
5-Year Change
-89.74%
All-Time (Max) Change
-86.03%

Contact Information

https://www.c4therapeutics.com
617 231 0700
490 Arsenal Way, Watertown, MA, 02472

Company Facts

110 Employees
IPO DateOct 2, 2020
CountryUS
Actively Trading

Frequently Asked Questions